Anaptysbio (ANAB) Retained Earnings (2016 - 2026)
Anaptysbio (ANAB) posted Retained Earnings of -$146000.0 for Q1 2026, down 508.33% on a QoQ basis from -$24000.0 in Q4 2025, and up 99.98% year-over-year from -$73006.7 in Q1 2025.
Anaptysbio (ANAB) Retained Earnings (2016 - 2026) Analysis & Trends
Anaptysbio's Retained Earnings history runs 11 years deep, the most recent figure standing at -$146000.0 for Q1 2026.
- Quarterly Retained Earnings rose 99.98% year-over-year to -$146000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$146000.0 (up 99.98% YoY) and the FY2025 annual result came in at -$24000.0, up 100.0% from the prior year.
- Retained Earnings was -$146000.0 for Q1 2026 at Anaptysbio, down from -$24000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $715.0 million in Q2 2024 and bottomed at -$822.2 million in Q3 2025.
- A 5-year average of -$52.2 million and a median of -$2.4 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings surged 353931.0% — and 2024, when it slumped 31284.81%.
- Anaptysbio's Retained Earnings stood at -$5.2 million in 2022, then surged by 13500.1% to $703.0 million in 2023, then tumbled by 208.02% to -$759.3 million in 2024, then soared by 100.0% to -$24000.0 in 2025, then sank by 508.33% to -$146000.0 in 2026.
- Business Quant data shows ANAB's Retained Earnings at -$146000.0 in Q1 2026, -$24000.0 in Q4 2025, and -$822.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Anaptysbio | 1.58 Bn | 1.29 Bn | - | -146,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -146,000.00 |
| Dec 31, 2025 | -24,000.00 |
| Sep 30, 2025 | -822.17 Mn |
| Jun 30, 2025 | -6,000.00 |
| Mar 31, 2025 | -798.66 Mn |
| Dec 31, 2024 | -759.33 Mn |
| Sep 30, 2024 | -737.54 Mn |
| Jun 30, 2024 | 714.96 Mn |
| Mar 31, 2024 | 706.41 Mn |
| Dec 31, 2023 | 702.97 Mn |
| Sep 30, 2023 | -2.35 Mn |
| Jun 30, 2023 | -534.58 Mn |
| Mar 31, 2023 | 689.07 Mn |
| Dec 31, 2022 | -5.25 Mn |
| Sep 30, 2022 | 707.66 Mn |
| Jun 30, 2022 | -390.56 Mn |
| Mar 31, 2022 | -358.01 Mn |
| Dec 31, 2021 | -422,000.00 |
| Sep 30, 2021 | -200,000.00 |
| Jun 30, 2021 | -282.55 Mn |